RC Law acted as US counsel to Chemo Project (Insud Pharma) and Becaril (Laboratorio Elea), as anchor investors, in the private placement of an aggregate amount of $130 million in SEC registered Procaps Group, S.A., a leading Latin America integrated pharmaceutical and healthcare company, headquartered in Luxembourg. The transaction also involved the restructuring of the company’s debt with its key financial lenders.

The private capital raise included a $90 million private placement of ordinary shares and the conversion of $40 million in secured convertible notes into ordinary shares of Procaps.  The issuance was subscribed by Chemo Project S.A., Becaril S.A., Flying Fish Ventures L.P., Saint Thomas Commercial S.A., Santana S.A., Hoche Partners Pharma Holding S.A. and other investors. As a result of the transaction, such investors hold approximately 90% of the Company’s equity.

RC Law team was led by Xavier Ruiz (Partner), Diego Price (Senior Associate) and Florencia Fernandez (Associate).  Heidi Steele (Partner) of McDermott Will & Emery acted as securities counsel while BSP acted as Luxembourg corporate counsel. Greenberg Traurig acted as counsel to the issuer.

For more information click here. 

RC Law acted as U.S. counsel to Global Media US LLC in its acquisition of the subsidiaries of Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) in Chile, Mexico, and Peru. Clear Channel is a global leader in the out-of-home advertising industry, while Global Media US LLC is a U.S. affiliate of Global Vía Pública, a Chilean group operating in the same sector.

RC Law LLP is proud to have advised Insud Pharma S.L., a global pharmaceutical group based in Spain, on its acquisition of Agile Therapeutics, Inc (OTCOB, AGRX) through the merger of the target company with one of the client’s US subsidiaries, as reported by Nasdaq on August 26, 2024. Loeb & Loeb LLP acted as co-counsel for Insud Pharma and the target and its shareholders were advised by Morgan, Lewis & Bockius LLP.

Source: https://www.nasdaq.com/press-release/agile-therapeutics-inc-announces-completion-acquisition-insud-pharma-sl-2024-08-26https://lnkd.in/eQCbEBx2

RC Law advised Teckel Medical S.L. (known as Mediktor) on the acquisition of Sensely, a California-based digital healthcare provider. Mediktor is a leading digital healthcare provider and as a result of the merger, one of the largest global AI-based solution providers in the healthcare ecosystem has been created.  RC Law acted as co-counsel, jointly with Baker & Mckenzie Spain.  Sensely was represented by Perkins Coie, California. RC Law’s team was led by Partner Xavier Ruiz and supported by Associates Diego Price, Florencia Fernandez and Carla Marco. Partner Marta Garcia advised on employment matters.  Mediktor is a long-standing client of the firm.

Press Release from Mediktor

Mediktor Acquires Sensely and Consolidates Its Position as a Leader in AI Healthcare Solutions

BARCELONA, ESP. and SAN FRANCISCO, CA. June 4th 2024 — Mediktor, the leading digital healthcare company, has announced the acquisition of Sensely, a San Francisco-based, digital healthcare provider that pioneered an empathy-driven conversation platform to support hospital systems and insurance services with world-class member engagement. This consolidation of two world-leading artificial intelligence-driven solutions providers marks a major medical technology milestone, extending Mediktor’s global presence to more than 35 countries and expanding its footprint in the United States.

The merger creates one of the largest global AI-based solutions providers in the healthcare ecosystem. The new organization will be driven by an enriched conversational healthcare platform to help increase efficiencies and reduce costs using its complementary technologies, including the company’s AI medical assistant. According to a recent survey of insurance customers, 54% of patients who used it were satisfied with the medical guidance it provided and did not need additional services or follow-up from a physician. 

“This acquisition is a transformational step for Mediktor and reinforces our commitment to digital health innovation. By joining forces with Sensely, we are poised to offer a leading top-notch AI solution to multiple businesses, ultimately improving millions of people’s access to healthcare,” states Cristian Pascual, Chief Executive Officer of Mediktor.

As a result of the integration, Mediktor will acquire educational healthcare content from Mayo Clinic, which was developed as part of a pre-existing agreement with Sensely. Mayo Clinic will also become a shareholder of the newly integrated company and hold a seat on the Board of Directors as an observer. 

MTIP, a leading Swiss-based growth equity firm and long-standing partner of Mediktor, has reaffirmed its confidence in the company’s vision and direction. As a member of the Mediktor Board of Directors,  MTIP has communicated its unwavering financial and strategic support of the company’s acquisition of Sensely and its overall growth strategy. 

At the same time, Aliath Bioventures, a venture capital firm that has been supporting Mediktor since 2018, also played a significant role in facilitating this acquisition. Aliath remains deeply committed to supporting Mediktor’s strategic growth, strengthening its market leadership, and long-term success.

“Mediktor and Sensely represent the perfect synergy between AI-based symptom assessment and empathy-driven virtual assistance that puts patients at the center,” said Adam Odessky, Sensely’s Co-Founder and CEO. “The combination of these two organizations provides customers with a strong, comprehensive suite of technology services that are proven to increase efficiency and reduce overhead costs for institutions while offering unparalleled personalized engagement services to patients and insurance members. We’re excited to share Mediktor’s vision for becoming a leading player in an evolving and competitive digital healthcare environment.”   

Mediktor plans to integrate Sensely’s current staff and management team into the new organization, where Mr. Odessky will take on the role of Chief Product Officer, bringing his vast experience and leadership to the team. 

About Mediktor

Mediktor is the most advanced AI-based medical chatbot for triage and pre-diagnosis that guides patients to the right level of care at the right time – improving access while enabling more efficient care navigation. Powered by a sophisticated AI engine that enables users to converse naturally in several languages, Mediktor’s white-labeled SaaS is omnichannel and can be easily embedded into any interface (web, mobile, desktop). Mediktor’s customers include health plans, hospitals and health systems, telehealth, and pharmaceutical companies. For more information, please visit www.mediktor.com

About Sensely

Sensely is a leading innovator of avatar and chatbot-based platforms that are designed to assist insurance plan members and patients with the insurance services and healthcare resources whenever they need them. With offices in San Francisco and London, Sensely’s global teams provide virtual assistant solutions to an array of diversified healthcare sectors, including insurance companies, hospital systems, and pharmaceutical clients worldwide. For more information, visit www.sensely.com.

About MTIP

MTIP is a Swiss-based growth equity firm investing in European healthtech companies that aim to revolutionize global healthcare. The team leverages deep sector expertise to help scale up successful and sustainable healthtech businesses For more information, visit www.mtip.ch.

About Aliath Bioventures

Aliath Bioventures, formerly known as Alta Life Sciences, is a life sciences venture capital firm part of the AltamarCAM group. Aliath aims to provide solutions to the most pressing healthcare challenges by targeting therapeutics and healthtech companies built on innovative and disruptive trends. For more information visit https://www.aliathbio.com/.

Source: https://www.mediktor.com/en-us/news/press/mediktor-acquires-sensely-and-consolidates-its-position-as-a-leader-in-ai-healthcare-solutions

RC Law represented Basque group KCE, S.L.U., as seller, on the sale of its interests in CTL Packaging USA, Inc., a North Carolina corporation, to ShawKwei & Partners, a Singapore/Hong-Kong private equity industrial investor.  The transaction was structured through a cash merger and included representations & warranties insurance financed by both parties equally.  CTL Packaging USA, Inc. is a company dedicated to the development and manufacturing of flexible tube packaging solutions for different sectors such as cosmetics, pharmaceuticals, oral care and food.  Partner Xavier Ruiz was the lead counsel for the seller and he was supported by associates Florencia Fernandez and Tamires Frasson. The buyer was represented by Hunton Andrews Kurth, Houston, TX office.